MedPath

Symyoo

Symyoo logo
🇰🇷South Korea
Ownership
Private
Employees
-
Market Cap
-
Website
http://www.symyoo.co.kr

Clinical Trials

3

Active:0
Completed:2

Trial Phases

3 Phases

Phase 2:1
Phase 3:1
Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (33.3%)
Phase 2
1 (33.3%)
Phase 3
1 (33.3%)

Trial of PED-1 in Male Patients With Premature Ejaculation

Phase 3
Completed
Conditions
Premature Ejaculation
Interventions
First Posted Date
2011-09-23
Last Posted Date
2012-10-03
Lead Sponsor
Symyoo
Target Recruit Count
159
Registration Number
NCT01439984
Locations
🇰🇷

Inje University Ilsan Paik Hospital, Goyang-si, Gyeonggi-do, Korea, Republic of

🇰🇷

National Health Insurance Corporation Ilsan Hospital, Goyang-si, Gyeonggi-do, Korea, Republic of

🇰🇷

Uijeongbu St.Marry's Hospital, Uijeongbu-si, Gyeonggi-do, Korea, Republic of

and more 2 locations

Phase 2 Trial of PED-1 and PED-2 in Male Patients With Premature Ejaculation

Phase 2
Completed
Conditions
Premature Ejaculation
Interventions
First Posted Date
2010-09-16
Last Posted Date
2012-10-03
Lead Sponsor
Symyoo
Target Recruit Count
104
Registration Number
NCT01203202
Locations
🇰🇷

Ewha University Mok-dong Hospital, Seoul, Korea, Republic of

🇰🇷

Seoul St. Marry's Hospital, Seoul, Korea, Republic of

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.